ScoreWhy is Anthem Biosciences Ltd ?
1
High Management Efficiency with a high ROE of 19.93%
2
The company is Net-Debt Free
3
Healthy long term growth as Net Sales has grown by an annual rate of 29.80% and Operating profit at 44.32%
4
Negative results in Dec 25
- PAT(Q) At Rs 110.87 cr has Fallen at -14.1% (vs previous 4Q average)
- NET SALES(Q) Lowest at Rs 423.15 cr
- PBDIT(Q) Lowest at Rs 157.19 cr.
5
With ROE of 17.7, it has a Very Expensive valuation with a 15.1 Price to Book Value
- Over the past year, while the stock has generated a return of NA, its profits have risen by 35%
6
Increasing Participation by Institutional Investors
- Institutional investors have increased their stake by 3.87% over the previous quarter and collectively hold 12.83% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Anthem Bioscienc should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
29.80%
EBIT Growth (5y)
44.32%
EBIT to Interest (avg)
56.77
Debt to EBITDA (avg)
0.16
Net Debt to Equity (avg)
-0.25
Sales to Capital Employed (avg)
0.62
Tax Ratio
28.85%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.83%
ROCE (avg)
32.59%
ROE (avg)
19.93%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
86
Industry P/E
34
Price to Book Value
15.15
EV to EBIT
69.13
EV to EBITDA
61.31
EV to Capital Employed
22.53
EV to Sales
22.95
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
32.59%
ROE (Latest)
17.74%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
Bollinger Bands
Bullish
KST
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-10What is not working for the Company
PAT(Q)
At Rs 110.87 cr has Fallen at -14.1% (vs previous 4Q average
NET SALES(Q)
Lowest at Rs 423.15 cr
PBDIT(Q)
Lowest at Rs 157.19 cr.
PBT LESS OI(Q)
Lowest at Rs 122.31 cr.
Loading Valuation Snapshot...
Here's what is not working for Anthem Bioscienc
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 122.31 cr has Fallen at -24.2% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 161.44 CrMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Net Sales - Quarterly
At Rs 423.15 cr has Fallen at -18.3% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 517.81 CrMOJO Watch
Near term sales trend is very negative
Net Sales (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 110.87 cr has Fallen at -14.1% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 129.04 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Net Sales - Quarterly
Lowest at Rs 423.15 cr
in the last five quartersMOJO Watch
Near term sales trend is negative
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Lowest at Rs 157.19 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 122.31 cr.
in the last five quartersMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
